Genesis Fringe Seminar

MHA are delighted to be hosting the Genesis Fringe Seminar: A UK-China approach to developing the right strategies for early-stage life science company growth.

We are hosting in collaboration with Medicilon and will be hearing from MHA, Freeths and Baker Tilly from a UK perspective and Medicilon from China, the seminar will discuss approaches to:

• IP Protection
• Market Entry
• How collaboration with a large Chinese CRO can support bio-partnering into China
• The latest pre-clinical technologies for generating pre-clinical data packages

Schedule:

• 18:00 - Registration and networking
• 18:30 - Welcome from Tony Jones, One Nucleus
• 18:35 - Introduction, Yogan A Patel, MHA/Baker Tilly, Partner Life Sciences
• 18:45 - What does an effective IP strategy for an early-stage biotech look like? Claus Andersen, Freeths
• 19:00 - Creating the right data packages for each stage of a life science company’s early growth Nadine Su, VP Strategic Partnerships & Business Development, Medicilon UK
• 19:15 - New Technology Platforms in Pre-Clinical Research, Dr Jing Deng, VP Pharmacology, Pharmodynamics and Biology Department, Medicilon
• 19:40 - Closing Remarks
• 19:50 - Networking
• 21:00 - Close

Drinks and Canapes will be served.